当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3805457
自主品牌
已选条件
-
T11824LLLanraplenibGS-9876
Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding t
价 格：￥电议型 号：T11824LL产 地：中国大陆
-
T11824Lanraplenib succinateLanraplenib succinate,GS-9876 succinate,
Lanraplenib succinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.?Lanraplenib succinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in devel
价 格：￥电议型 号：T11824产 地：美洲
-
T11824LLLanraplenibLanraplenib,GS-9876,
Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treat
价 格：￥电议型 号：T11824LL产 地：美洲
-
T11824LLLanraplenib；化合物LanraplenibGS-9876；GS-9876
Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.
价 格：￥电议型 号：T11824LL产 地：中国大陆
-
T11824LLanraplenib monosuccinate；化合物 T11824LGS-9876 monosuccinate；GS-9876 monosuccinate
Lanraplenib monosuccinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib monosuccinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
价 格：￥电议型 号：T11824L产 地：中国大陆
-
T11824Lanraplenib succinate化合物 T11824GS-9876 succinate
Lanraplenib succinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib succinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
价 格：￥电议型 号：T11824产 地：中国大陆
